Apogee Therapeutics announces $350M common stock offering
The Fly

Apogee Therapeutics announces $350M common stock offering

Apogee Therapeutics announced that it has commenced an underwritten public offering of approximately $350M of shares of its common stock. All of the securities are being offered by Apogee. Jefferies, BofA Securities, Goldman Sachs, TD Cowen, and Stifel are acting as joint book-running managers for the proposed offering.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on APGE:

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App